These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6890820)

  • 1. Enhancement of myocardial reactive hyperemia and adenosine-induced coronary vasodilation by dilazep, a new adenosine potentiator.
    Saito D; Kusachi S; Nagashima H; Haraoka S
    Arzneimittelforschung; 1982; 32(9):1029-32. PubMed ID: 6890820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dilazep on regional myocardial blood flow during selective coronary hypotension.
    Fujii M; Kikuchi Y; Koyanagi S; Okamatsu S; Tomoike H; Nakamura M
    Arzneimittelforschung; 1981; 31(12):2067-71. PubMed ID: 7199300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dilazep on decrease in myocardial pH during ischemia in dogs.
    Haga N; Miura I; Fujisawa Y; Fukushi Y; Abiko Y
    Arzneimittelforschung; 1986 Jun; 36(6):913-6. PubMed ID: 3741523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of quinacrine on myocardial reactive hyperemia in the dog.
    Kimura T; Satoh S
    J Pharmacol Exp Ther; 1985 Jan; 232(1):269-74. PubMed ID: 3965697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary adenosine enhances myocardial reactive hyperemia after brief coronary occlusion.
    Saito D; Hyodo T; Takeda K; Abe Y; Tani H; Yamada N; Ueeda M; Nakatsu T
    Am J Physiol; 1985 Jun; 248(6 Pt 2):H812-7. PubMed ID: 4003561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N; Katsuki S; Kawada M
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract]   [Full Text] [Related]  

  • 7. Improvement of reduced coronary vasodilatory response during reactive hyperemia by diltiazem.
    Saito D; Ueeda M; Yamada N; Hina K; Watanabe H; Mima T; Hasui M; Kusachi S; Haraoka S; Tsuji T
    Arzneimittelforschung; 1989 Apr; 39(4):440-5. PubMed ID: 2502126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progressive increase of the coronary flow above peak reactive hyperemia during prolonged intracoronary infusion of adenosine (author's transl)].
    L'Abbate A; Trivella MG; Camici P; Pelosi G; Marzilli M; Ballestra AM; Levantesi D; Taddei L
    G Ital Cardiol; 1981; 11(4):430-40. PubMed ID: 7286516
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myocardial protection by dilazep in myocardial ischemia and reperfusion].
    Shida H; Kobayashi M; Chiba S
    Arzneimittelforschung; 1981; 31(11):1902-6. PubMed ID: 7198472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenosine degradation in human erythrocytes in the presence of dilazep].
    Blum KU; Merkel R
    Arzneimittelforschung; 1976; 26(9):1638-42. PubMed ID: 1036691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
    Katano Y; Takeda K; Otorii T; Horii D; Imai S
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
    Lenke D; Brock N; Zechel HJ
    Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of adenosine compounds of the vascular bed and effects of dilazep, theophylline, and indomethacin on blood flow changes of the postocclusive renal vessels].
    Ohtaki Y; Nakanishi H; Ueda J
    Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):93-102. PubMed ID: 558949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-nitro-L-arginine on coronary artery tone and reactive hyperemia after brief coronary occlusion in conscious dogs.
    Muramatsu K; Numaguchi K; Egashira K; Takahashi T; Kasuya H; Takeshita A
    Coron Artery Dis; 1994 Oct; 5(10):815-20. PubMed ID: 7866601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dilazep on coronary and systemic circulations.
    Marzilli M; Trivella MG; Levantesi D; Pelosi G; Dalle Vacche M; Taddei L; L'Abbate A
    Pharmacology; 1985; 31(2):82-7. PubMed ID: 4023048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system effects and behavioral interactions with ethanol of centrally administered dilazep and its metabolites in mice.
    Dar MS
    Eur J Pharmacol; 1989 May; 164(2):303-13. PubMed ID: 2759178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model.
    van Giezen JJ; Sidaway J; Glaves P; Kirk I; Björkman JA
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):164-72. PubMed ID: 21697355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dilazep on reperfusion arrhythmias.
    Sugiyama S; Kondo T; Ajioka M; Hattori M; Nagai S; Ozawa T
    Arzneimittelforschung; 1985; 35(12):1802-4. PubMed ID: 4096732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dilazep].
    Pirani R; Gruppillo P
    G Ital Cardiol; 1980; 10(10):1419-25. PubMed ID: 7016654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.